)
At Acadia, our mission is to turn scientific promise into meaningful innovation that makes the difference for underserved neurological disorders and rare disease communities around the world. Currently, our clinical-stage developments focus on addressing Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with early-stage programs that address other unmet patient needs.
Leading the Way in Rett Syndrome Therapy
Our commitment is unwavering towards creating a brighter future for individuals living with rare diseases and their families. Our efforts continue to focus on broadening access to essential therapies for families across the globe.
)